Lotus Pharmaceuticals, Inc. (LTUS)

Market Cap	15.34M
Revenue (ttm)	71.39M
Net Income (ttm)	1.72M
Shares Out	2.64B
EPS (ttm)	0.06
PE Ratio	0.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	36,247
Open	0.0060
Previous Close	n/a
Day's Range	0.0060 - 0.0060
52-Week Range	0.0006 - 0.0079
Beta	-2.64
RSI	51.45
Earnings Date	n/a

About Lotus Pharmaceuticals

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.

• Industry: Shell Companies
• Sector: Financials
• CEO: Zhong Yi Liu
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: LTUS

Financial Performance

In 2010, Lotus Pharmaceuticals's revenue was $72.70 million, an increase of 28.71% compared to the previous year's $56.48 million. Earnings were $14.42 million, a decrease of -12.22%.